Re: V. Usonis et al.: Comparative study of reactogenicity and immunogenicity of new and established measles, mumps and rubella vaccines in healthy children (Infection 26 (1998) 222-226) (letter)

Nalin D

首页> 外文期刊>Infection >Re: V. Usonis et al.: Comparative study of reactogenicity and immunogenicity of new and established measles, mumps and rubella vaccines in healthy children (Infection 26 (1998) 222-226) (letter)

【24h】

Re: V. Usonis et al.: Comparative study of reactogenicity and immunogenicity of new and established measles, mumps and rubella vaccines in healthy children (Infection 26 (1998) 222-226) (letter)

机译：回复：V。Usonis等：健康儿童中新的和确定的麻疹，腮腺炎和风疹疫苗的反应原性和免疫原性的比较研究（感染26（1998）222-226）（字母）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Infection》 |1999年第2期|共2页
作者
Nalin D;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类传染病;
关键词
Measles Vaccine; Mumps Vaccine; Rubella Vaccine; measles; mumps; rubella vaccine; 麻疹疫苗; 腮腺炎疫苗; 风疹疫苗;

机译：Measles Vaccine;Mumps Vaccine;Rubella Vaccine;measles;mumps;rubella vaccine;麻疹疫苗;腮腺炎疫苗;风疹疫苗;
入库时间 2022-08-18 10:29:23

相似文献

外文文献
中文文献

1. Re: V. Usonis et al.: Comparative study of reactogenicity and immunogenicity of new and established measles, mumps and rubella vaccines in healthy children (Infection 26 (1998) 222-226) (letter) [J] . Nalin D Infection . 1999,第2期

机译：回复：V。Usonis等：健康儿童中新的和确定的麻疹，腮腺炎和风疹疫苗的反应原性和免疫原性的比较研究（感染26（1998）222-226）（字母）
2. Immunogenicity and reactogenicity of tetravalent vaccine for measles, mumps, rubella and varicella (MMRV) in healthy children: a meta-analysis of randomized controlled trials [J] . Leung Julia H. Y., Hirai Hoyee W., Tsoi Kelvin K. F. Expert review of vaccines . 2015,第8期

机译：四价疫苗对健康儿童麻疹，腮腺炎，风疹和水痘的免疫原性和反应原性：一项随机对照试验的荟萃分析
3. Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine [J] . Gillet Y, Steri GC, Behre U, Vaccine . 2009,第3期

机译：接种麻疹-腮腺炎-风疹（MMR）疫苗的15个月至2岁或2-6岁的儿童接种麻疹-腮腺炎-风疹-水痘（MMRV）疫苗的免疫原性和安全性
4. A second dose of a measles-mumps-rubella vaccine administered to healthy four-to-six-year-old children: a phase III observer-blind randomized safety and immunogenicity study comparing GSK MMR and MMR II with and without DTaP-IPV and varicella vaccines co-administration [O] . 2019

机译：向健康的4至6岁儿童接种第二剂麻疹-腮腺炎-风疹疫苗：一项III期观察者盲随机安全性和免疫原性研究比较了GSK MMR和MMR II（含或不含DTaP-） IPV和水痘疫苗的共同给药
5. A new measles mumps rubella (MMR) vaccine: a randomized comparative trial for assessing the reactogenicity and immunogenicity of three consecutive production lots and comparison with a widely used MMR vaccine in measles primed children [O] . Lee Chin-Yun, Tang Ren-Bin, Huang Fu-Yuan, 2002

机译：一种新的麻疹腮腺炎风疹（MMR）疫苗：一项随机比较试验，用于评估三个连续生产批次的反应原性和免疫原性，并与在麻疹致敏儿童中广泛使用的MMR疫苗进行比较
6. Randomized Double-Blind Phase III Pivotal Field Trial of the Comparative Immunogenicity Safety and Tolerability of Two Yellow Fever 17D Vaccines (ARILVAX(Trademark) and YF-VAX(Trademark)) in Healthy Infants and Children in Peru [R] . Belmusto-Worn, V. E. , Sanchez, J. L. , McCarthy, K. , 2004

机译：秘鲁健康婴儿和儿童两种黄热病17D疫苗（aRILVaX（商标）和YF-VaX（商标））的比较免疫原性安全性和耐受性的随机双盲III期关键现场试验

Re: V. Usonis et al.: Comparative study of reactogenicity and immunogenicity of new and established measles, mumps and rubella vaccines in healthy children (Infection 26 (1998) 222-226) (letter)

著录项

相似文献

相关主题

期刊订阅